Amarin Corp Plc (AMRN)

[linhdtu]

I disagree with this logic.
--
If they did deny Anchor, AMRN will likely not be able to afford REDUCE IT and FDA doesn't get the results it wants to see.
--
It reminds me of JL opinion why NCE for V was a sure thing. Why would the FDA bother requiring an expensive long term outcome trial from amrn unless they intend to grant NCE. You can check with him on that although I'm quite sure I remember right.

If Reduce It can't be finished then somebody else with more secure funding can do the same thing later.